Latest filing published 22 Jan 2026 for Pliant Therapeutics, INC., €98k.
Filing timeline
BuySaleInsider track record
Bernard Coulie: trading record in brief
Bernard Coulie is a declared insider of Pliant Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 30 April 2020 and 20 January 2026, the trades on record add up to 80 filings.
The open-market record consists of 51 sales worth €12.5M, with no purchase. The rest of the record consists of 7 share grants and 21 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 22 January 2026, reports an open-market sale of €98k in Pliant Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bernard Coulie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 89,375 shares@ US$1.280.18% mcap2.5% of flowCommon StockSEC:0001746473-26-000009:0
- 162,500 shares0Common StockSEC:0001746473-25-000009:0
- 52,419 shares@ US$11.201114.6% of flowCommon StockSEC:0001746473-25-000006:0
- 38,710 shares@ US$11.5610.6% of flowCommon StockSEC:0001746473-24-000123:0
- 75,625 shares0Common StockSEC:0001746473-24-000113:0
- 128,150 shares0Common StockSEC:0001746473-24-000012:0
- 25,721 shares@ US$17.2310.4% of flowCommon StockSEC:0001746473-24-000003:0
- 70,150 shares@ US$18.009128.8% of flowCommon StockSEC:0001209191-23-042823:0
- 137,500 shares0Common StockSEC:0001209191-23-042654:0
- 35,339 shares@ US$26.520922.0% of flowCommon StockSEC:0001209191-23-022362:0
- 68,749 shares0Common StockSEC:0001209191-23-021915:0
- 15,000 shares@ US$6.221.9% of flowCommon StockSEC:0001140361-23-004735:3
- 13,395 shares@ US$34.13Common StockSEC:0001140361-23-004735:1
- 1,605 shares@ US$34.96Common StockSEC:0001140361-23-004735:2
- 9,738 shares@ US$33.36Common StockSEC:0001140361-23-004735:4
- 5,262 shares@ US$34.08Common StockSEC:0001140361-23-004735:5
- 15,000 shares@ US$6.222.2% of flowCommon StockSEC:0001140361-23-004735:0
- 10,539 shares@ US$2.080.5% of flowCommon StockSEC:0001140361-23-003977:3
- 4,461 shares@ US$6.220.6% of flowCommon StockSEC:0001140361-23-003977:4
- 15,000 shares@ US$6.221.9% of flowCommon StockSEC:0001140361-23-003977:6
- 105 shares@ US$35.550.0% of flowCommon StockSEC:0001140361-23-003977:9
- 11,395 shares@ US$33.98Common StockSEC:0001140361-23-003977:1
- 3,605 shares@ US$34.66Common StockSEC:0001140361-23-003977:2
- 15,000 shares@ US$34.92Common StockSEC:0001140361-23-003977:5
- 9,455 shares@ US$34.15Common StockSEC:0001140361-23-003977:7
25 of 80 declarations